Short answer: yes, there are patent applications and patent families around biosynthetic (including chemoenzymatic) production of heparin and related heparan sulfate polysaccharides. The area covers (a) chemoenzymatic synthesis of heparan sulfate/heparin with defined sulfation patterns, (b) production of heparosan precursors in recombinant microbes or cells followed by enzymatic modification to heparin, and (c) recombinant or enzymatic approaches to assemble biochemically defined HS/heparin in vitro or in vivo.
What to look for if you’re researching or filing
- Claim themes you’ll often see
- Methods for producing heparan sulfate or heparin using specific sulfotransferases, epimerases, and other HS biosynthetic enzymes in engineered hosts or in cell-free systems.
- Recombinant production of HS/heparin or its precursors (e.g., heparosan) in microbes or cell lines, with downstream enzymatic modification to achieve the desired sulfation pattern.
- Chemoenzymatic workflows that start from a polysaccharide precursor (like heparosan or an equivalent) and use defined enzymes to install N-/O-sulfation and epimerization to create heparin.
- Defined, reproducible sulfation patterns or sequences of oligosaccharides with therapeutic activity, plus methods to purify and characterize them.
- Methods to ensure product safety, quality, and potency (e.g., GMP-compatible processes, control strategies) in biosynthetic routes.
- Typical jurisdictions and audiences
- U.S. and international (PCT/EPO/WO) filings are common in this space, with academic groups (notably those working on glycosaminoglycan biosynthesis) and biotech companies pursuing these claims.
- Common assignees you may encounter
- Academic institutions with active glycosaminoglycan research programs.
- Biotechnology or pharmaceutical companies pursuing alternative production routes for heparin due to safety, supply, or regulatory concerns.
How to efficiently search
- Databases to use
- USPTO PatFT and AppFT (US)
- Espacenet (EPO)
- WIPO Patentscope (PCT)
- Google Patents (cross-referenced)
- Keywords and search strings
- “heparin biosynthesis”
- “heparan sulfate biosynthesis”
- “chemoenzymatic synthesis of heparin”
- “recombinant production of heparin”
- “biosynthetic production of heparosan”
- “heparosan to heparin enzymatic modification”
- “EXT1” OR “EXT2” OR “NDST” OR “HS3ST” in conjunction with heparan sulfate/heparin
- “glycosaminoglycan biosynthesis” AND “patent”
- How to map results
- Group by whether the claim covers: (1) organism/host engineering, (2) specific enzymatic steps, (3) starting materials/preparations (e.g., heparosan), (4) defined sulfation patterns, (5) product safety/quality claims.
- Note the scope: some patents claim the process as a whole, others claim a particular enzyme combination or a particular sulfation pattern or oligosaccharide sequence.
If you want, I can help you with a targeted, initial landscape you can use as a starting point:
- Tell me the jurisdictions you care about (e.g., US, EU, China, PCT).
- Tell me whether you want a broad landscape or a focus on chemoenzymatic approaches vs. microbial production.
- Share whether you want a high-level summary of key families or a more detailed claim-chart-type pull (claim scope, dependent claims, priority dates).
A few caveats
- This is a rapidly evolving field; patent families can be large and have continuations. A current, edge-updated search is best done in patent databases.
- Biosynthesis of heparin touches on complex enzyme cascades and regulatory-quality concerns. If you’re evaluating freedom-to-operate or planning to file, you’ll want a formal patent search and potentially a patent attorney’s analysis.
Would you like me to help you draft a concrete search plan for a specific jurisdiction (US/EU/WO), or do a high-level synthetic landscape summary based on publicly known families? If you have a target assignee or a date window, I can tailor the plan accordingly.